![Sasha Austin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sasha Austin
Comptroller/Controller/Auditor bei
OLEMA PHARMACEUTICALS, INC.
Vermögen: 213 520 $ am 31.05.2026
Profil
Sasha Austin currently works at The American Institute of Certified Public Accountants, as Member and Olema Pharmaceuticals, Inc., as Vice President-Finance & Controller from 2023.
Ms. Austin also formerly worked at GigCapital Global, as Controller from 2020 to 2021.
Ms. Austin received her undergraduate degree from Seattle University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.02.2026 | 16 188 ( 0,02 % ) | 213 520 $ | 31.05.2026 |
Aktive Positionen von Sasha Austin
| Unternehmen | Position | Beginn |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.04.2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sasha Austin
| Unternehmen | Position | Ende |
|---|
Ausbildung von Sasha Austin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Wählen Sie MarketScreener 
